UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 757

Sortiert nach

111Indium-pentetreotide pituitary scintigraphy and hormonal responses to octreotide in acromegalic patients

Journal of endocrinological investigation, 1997-07, Vol.20 (7), p.424-428

1997

Volltextzugriff (PDF)

119P The role of circulating markers in predicting immune-related adverse events (irAEs) and their recurrence in advanced non-small cell lung cancer (aNSCLC) patients (pts)

Journal of thoracic oncology, 2021-04, Vol.16 (4), p.S763-S763

2021

Volltextzugriff (PDF)

1244PDOUBLE BLIND RANDOMIZED PHASE III STUDY OF MAINTENANCE PAZOPANIB® (PZ) VERSUS PLACEBO (P) IN NON SMALL CELL LUNG CANCER (NSCLC) PATIENTS (PTS) NON PROGRESSIVE AFTER FIRST LINE CHEMOTHERAPY [CT] (EORTC LUNG CANCER GROUP, 08092): MAPPING

Annals of oncology, 2014-09, Vol.25 (suppl_4), p.iv435-iv436

2014

Volltextzugriff (PDF)

1296P Immune checkpoint inhibitors with or without bone targeted therapy in NSCLC patients with bone metastases and prognostic significance of neutrophil-to-lymphocyte ratio

Annals of oncology, 2021-09, Vol.32, p.S1004-S1005

2021

Volltextzugriff (PDF)

149P First-line (1L) osimertinib in EGFR mutant (mut) advanced non-small cell lung cancer (aNSCLC) patients (pts): Progression (PD) pattern and safety in the real-world (RW)

Journal of thoracic oncology, 2021-04, Vol.16 (4), p.S779-S779

2021

Volltextzugriff (PDF)

1618P Impact of body composition phenotypes on outcome of non-small cell lung cancer patients treated with immunotherapy

Annals of oncology, 2022-09, Vol.33, p.S1281-S1282

2022

Volltextzugriff (PDF)

1640P Impact of COVID-19 vaccination campaign on psychological status in cancer patients (pts)

Annals of oncology, 2021-09, Vol.32, p.S1159-S1159

2021

Volltextzugriff (PDF)

1675P Potential effect of adipose tissue distribution on clinical outcomes in advanced non-small cell lung cancer (NSCLC) patients (pts) receiving first-line pembrolizumab (PEMBRO)

Annals of oncology, 2021-09, Vol.32, p.S1176-S1177

2021

Volltextzugriff (PDF)

181P Multicenter real-world study (RWS) on efficacy and early discontinuation predictors in non-small cell lung cancer (NSCLC) patients (pts) receiving nivolumab

Journal of thoracic oncology, 2021-04, Vol.16 (4), p.S796-S796

2021

Volltextzugriff (PDF)

1857P Choose health, oncological patients centered exercise (CHOiCE): Preliminary findings of a pilot randomized controlled trial

Annals of oncology, 2021-09, Vol.32, p.S1249-S1250

2021

Volltextzugriff (PDF)

18F-FDG PET/CT in non-small-cell lung cancer patients: a potential predictive biomarker of response to immunotherapy

Nuclear medicine communications, 2019-08, Vol.40 (8), p.802

2019

Volltextzugriff (PDF)

3023 Pan-European survey on thymic malignancies: A collaboration of the EORTC Lung Cancer Group (LCG) with the RYTHMIC network

European journal of cancer (1990), 2015-09, Vol.51, p.S604-S604

2015

Volltextzugriff (PDF)

3638 POSTER Integrated Care Pathways for Non Small Cell Lung Cancer (NSCLC) Patients: Avoidable Costs Analysis in a Quality Improvement Project

European journal of cancer (1990), 2011, Vol.47, p.S270-S270

2011

Volltextzugriff (PDF)

4 cases of pregnancy in patients with heart valve prosthesis

Annali di ostetricia, ginecologia, medicina perinatale, 1977-09, Vol.98 (5), p.330

1977

Volltextzugriff (PDF)

438O - METEOR-1: A phase I study of GSK3326595, a first-in-class protein arginine methyltransferase 5 (PRMT5) inhibitor, in advanced solid tumours

Annals of oncology, 2019-10, Vol.30, p.v159-v159

2019

Volltextzugriff (PDF)

438OMETEOR-1: A phase I study of GSK3326595, a first-in-class protein arginine methyltransferase 5 (PRMT5) inhibitor, in advanced solid tumours

Annals of oncology, 2019-10, Vol.30 (Supplement_5)

2019

Volltextzugriff (PDF)

55 A single–site comparison of laparoscopic versus open radical nephrectomy: Length of postoperative hospital stay

European urology supplements : official journal of the European Association of Urology, 2015-05, Vol.14 (3), p.e1151-e1151

2015

Volltextzugriff (PDF)

9044 Curative surgery in oligometastatic non-small cell lung cancer patients

European journal of cancer supplements, 2009, Vol.7 (2), p.518-519

2009

Volltextzugriff (PDF)

9P Circulating tumour cells (CTCs) count and PD-L1 expression in untreated extensive small cell lung cancer patients treated in the REACTION trial, a phase II study of etoposide and cis/carboplatin with or without pembrolizumab (NCT02580994)

Annals of oncology, 2020-12, Vol.31, p.S1420-S1420

2020

Volltextzugriff (PDF)

Abstract

International journal of educational research, 1992-01, Vol.17 (3), p.265

1992

Volltextzugriff (PDF)

Abstract CT141: Safety and efficacy results from a phase I dose-escalation trial of Nintedanib in combination with Pembrolizumab in patients with advanced solid tumors (PEMBIB trial)

Cancer research (Chicago, Ill.), 2018-07, Vol.78 (13_Supplement), p.CT141-CT141

2018

Volltextzugriff (PDF)

Ação antimicrobiana do gás ozônio em superfícies e na aeromicrobiota

Acta paulista de enfermagem, 2021-04, Vol.34

2021

Volltextzugriff (PDF)

Accuracy Of The Speed Estimation In The Sensorless Induction Motor Drives Based On The Mras Technique

Proceedings of the 6th International Conference on Optimization of Electrical and Electronic Equipments, 1998, Vol.2, p.407-414

1998

Volltextzugriff (PDF)

Acoustic recordings and modeling under seasonally varying sea ice

Scientific reports, 2019-06, Vol.9 (1), p.8323-8323, Article 8323

2019

Volltextzugriff (PDF)

Acquisition of private ownership over land plots in Russia by virtue of acquisitive prescription

Journal of property, planning and environmental law, 2020-03, Vol.12 (1), p.72-86

2020

Volltextzugriff (PDF)

1 – 25 von 757

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(608)
Mit Volltextzugriff
(654)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

4 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(383)
Life Sciences & Biomedicine
(265)
Humans
(216)
Female
(130)
Male
(106)
Adult
(72)
Technology
(67)
Middle Aged
(65)
Oncology
(58)
Engineering
(57)
Aged
(52)
Physical Sciences
(52)
Chemistry
(49)
Animals
(46)
Biological And Medical Sciences
(46)
Endocrinology & Metabolism
(45)
Engineering, Electrical & Electronic
(42)
Medical Sciences
(39)
Vaccines
(33)
Retrospective Studies
(30)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

111Indium-pentetreotide pituitary scintigraphy and hormonal responses to octreotide in acromegalic patients

119P The role of circulating markers in predicting immune-related adverse events (irAEs) and their recurrence in advanced non-small cell lung cancer (aNSCLC) patients (pts)

1244PDOUBLE BLIND RANDOMIZED PHASE III STUDY OF MAINTENANCE PAZOPANIB® (PZ) VERSUS PLACEBO (P) IN NON SMALL CELL LUNG CANCER (NSCLC) PATIENTS (PTS) NON PROGRESSIVE AFTER FIRST LINE CHEMOTHERAPY [CT] (EORTC LUNG CANCER GROUP, 08092): MAPPING

1296P Immune checkpoint inhibitors with or without bone targeted therapy in NSCLC patients with bone metastases and prognostic significance of neutrophil-to-lymphocyte ratio

149P First-line (1L) osimertinib in EGFR mutant (mut) advanced non-small cell lung cancer (aNSCLC) patients (pts): Progression (PD) pattern and safety in the real-world (RW)

1618P Impact of body composition phenotypes on outcome of non-small cell lung cancer patients treated with immunotherapy

1640P Impact of COVID-19 vaccination campaign on psychological status in cancer patients (pts)

1675P Potential effect of adipose tissue distribution on clinical outcomes in advanced non-small cell lung cancer (NSCLC) patients (pts) receiving first-line pembrolizumab (PEMBRO)

181P Multicenter real-world study (RWS) on efficacy and early discontinuation predictors in non-small cell lung cancer (NSCLC) patients (pts) receiving nivolumab

1857P Choose health, oncological patients centered exercise (CHOiCE): Preliminary findings of a pilot randomized controlled trial

18F-FDG PET/CT in non-small-cell lung cancer patients: a potential predictive biomarker of response to immunotherapy

3023 Pan-European survey on thymic malignancies: A collaboration of the EORTC Lung Cancer Group (LCG) with the RYTHMIC network

3638 POSTER Integrated Care Pathways for Non Small Cell Lung Cancer (NSCLC) Patients: Avoidable Costs Analysis in a Quality Improvement Project

4 cases of pregnancy in patients with heart valve prosthesis

438O - METEOR-1: A phase I study of GSK3326595, a first-in-class protein arginine methyltransferase 5 (PRMT5) inhibitor, in advanced solid tumours

438OMETEOR-1: A phase I study of GSK3326595, a first-in-class protein arginine methyltransferase 5 (PRMT5) inhibitor, in advanced solid tumours

55 A single–site comparison of laparoscopic versus open radical nephrectomy: Length of postoperative hospital stay

9044 Curative surgery in oligometastatic non-small cell lung cancer patients

9P Circulating tumour cells (CTCs) count and PD-L1 expression in untreated extensive small cell lung cancer patients treated in the REACTION trial, a phase II study of etoposide and cis/carboplatin with or without pembrolizumab (NCT02580994)

Abstract

Abstract CT141: Safety and efficacy results from a phase I dose-escalation trial of Nintedanib in combination with Pembrolizumab in patients with advanced solid tumors (PEMBIB trial)

Ação antimicrobiana do gás ozônio em superfícies e na aeromicrobiota

Accuracy Of The Speed Estimation In The Sensorless Induction Motor Drives Based On The Mras Technique

Acoustic recordings and modeling under seasonally varying sea ice

Acquisition of private ownership over land plots in Russia by virtue of acquisitive prescription

Suchergebnisse filtern